General Information of the Compound
| Compound ID |
CP0386221
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-1-(6-methoxy-1H-indazol-1-yl)propan-2-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
(2S)-1-(6-methoxy-1H-indazol-1-yl)propan-2-amine
(S)-2-(6-methoxyindazol-1-yl)-1-methylethylamine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H15N3O
|
||||||||||||||||||
| Molecular Weight |
205.261
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc2cnn(C[C@H](C)N)c2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H15N3O/c1-8(12)7-14-11-5-10(15-2)4-3-9(11)6-13-14/h3-6,8H,7,12H2,1-2H3/t8-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
WSEWULCWBQDNEH-QMMMGPOBSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Protein ID: PT01480, 5-hydroxytryptamine receptor 2C
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Clinical Information about the Compound